Emerging Players The emerging players in the glucagon-like peptide 1 (GLP-1) analogues market include Gmax Biopharm., Sciwind Biosciences Co., Ltd., Teva Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC (Hikma), Viking Therapeutics, Terns Pharmaceuticals, Inc., Altimmune, AVVA Pharmaceuticals Ltd, LEXICARE PHARMA PVT
The drug is doing exactly what it was designed to do modulating reward signaling but that modulation extends beyond food to include alcohol, nicotine, and potentially other substances
Jessie Cheung is a board-certified dermatologist in Willowbrook, IL Doris Day, MD is a board-certified dermatologist in New York Common Nutrient Deficiencies on GLP-1 Medications As appetite decreases and food intake drops while taking a GLP-1, it can be harder to meet your bodys daily nutritional needs
Discuss severe or persistent gastrointestinal symptoms that may be contributing to mood disturbances
,
GLP-1 weight loss drugs can have an indirect impact on electrolyte balance